GREAT TREE PHARMACY COLTD Business Summary

Great Tree Pharmacy Co., Ltd. (6469.TWO) operates as Taiwan’s leading professional pharmacy chain, generating revenue primarily through high-volume retail transactions and service fees from National Health Insurance (NHI) prescription dispensing. The company’s business model is diversified across four primary segments: maternal and infant products, prescription medications, health supplements, and medical supplies, supplemented by a growing "Great Tree Pet" division focused on wholesale pet food and grooming. As of early 2026, the company continues its aggressive "Five-Year Plan" expansion, targeting a network of over 500 stores to solidify its O2O (online-to-offline) ecosystem. In the competitive landscape, Great Tree maintains a dominant position in the professional pharmacy sector, outperforming specialized peers like MedFirst Healthcare and Norbel Baby, while strategically positioning itself against diversified retail giants such as President Chain Store Corp (7-Eleven Taiwan) and Taiwan FamilyMart through its specialized healthcare expertise. The company was founded in 2001 by Ming-Lung Cheng, who currently serves as Chairman and CEO, bringing a background in systematic management from his tenure at Sinyi Realty to the pharmaceutical retail space. The executive leadership team includes Shu-Yi Wu as Chief Financial Officer, Feng-Sheng Huang as Chief Operating Officer, and Da-Hong Cheng as Chief Administrative Officer, a seasoned group that has overseen the firm’s growth from a local Taoyuan operation to a national powerhouse. Notable strategic backing is provided by Japan’s Sugi Holdings Co., Ltd., which maintains a significant partnership and investment stake to facilitate cross-border product integration. Other major institutional shareholders include Junwei Investment Co., Ltd. and global asset managers such as The Vanguard Group and BlackRock, reflecting strong investor confidence in the company’s scalable healthcare retail model.